Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
Clinical trial NCT04975256 · TERMINATED
Trial details
- NCT number
- NCT04975256
- Sponsor
- Mirati Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2022-11-02
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.